The Anti-BAFF (Belimumab Biosimilar) Monoclonal Antibody (HDbs0044) is a cutting-edge tool for researchers studying B-cell activating factor (BAFF), a key protein involved in B-cell survival and maturation. This antibody, developed as a biosimilar to the well-known drug Belimumab, is optimized for use in a variety of applications, including ELISA, Western blot, and immunohistochemistry.BAFF, also known as B-lymphocyte stimulator, is a cytokine that plays a crucial role in regulating B-cell function and antibody production. Dysregulation of BAFF signaling has been linked to autoimmune diseases, such as systemic lupus erythematosus, making it a promising target for therapeutic intervention.
The Anti-BAFF Monoclonal Antibody (HDbs0044) specifically binds to BAFF, allowing for the precise detection and quantification of this protein in complex biological samples.By using this antibody, researchers can gain valuable insights into the role of BAFF in various disease states and potentially discover new therapeutic approaches for treating autoimmune disorders and other conditions characterized by immune dysregulation. Its high specificity and sensitivity, along with its versatility in multiple assay formats, make the Anti-BAFF Monoclonal Antibody (HDbs0044) a valuable tool for advancing research in immunology and drug development.
Product Name:
Belimumab (Anti-BAFF) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0044
Target:
BAFF
Host Species:
Homo sapiens
Reactivity:
Human
Recommended Dilution:
ELISA 1:5000-10000
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
LymphoStat-B, hBlySmAb-1.1
Description:
Anti-BAFF (belimumab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
